Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
, immunoprecipitation (IP), cell culture, immunofluorescence (IF), qRT-PCR, Western blotting, and CRISPR/Cas9 gene editing. Scientific Proficiency: A proven track record of independent experimental design
-
, including use of CRISPR, is strongly desired. In this role, you will: Plan approach to experiments in support of research projects in lab and/or field based on knowledge of scientific theory. Independently
-
single photon counting, nucleoproteins, CRISPR/CAS9, riboswitches, high pressure The ability to “see” single biomolecules with laser microscopy has led to a revolution in research opportunities
-
CRISPR-based gene editing in the salmon louse. The small size of its oocytes poses a challenge for the delivery of the gene editing compounds. Therefore, CRISPR is not available in this species, yet. To
-
disease. They are also conducting advanced CRISPR screens to interrogate the complex genetic basis of these disorders. The lab has been supported by the ERC for the past 15 years. Now we are seeking a
-
fundamental and translational aspects of infectious disease (germfree/gnotobiotic animal facility, organoid cultures, T-cell engineering via CRISPR/Cas9 technology, in vivo imaging, animal models, microbiome
-
the University of Vienna: https://doschem.univie.ac.at/ The standard employment contract is for three years . Initially limited to 1.5 years, the employment relationship is automatically extended to three years
-
screening (e.g., CRISPR-based or related screening approaches), viral infection models, and insect or arthropod cell culture systems. The successful candidate will work with Norbert Perrimon to develop and
-
mouse models. Key responsibilities include CRISPR/Cas9-mediated generation of global and cell-specific gene knockout mice, mouse colony management, and molecular validation. Perform immunological and
-
these questions, we use a novel multi-omics approach that integrates high-throughput imaging and machine learning methods with CRISPR/Cas9 screens and saturation mutagenesis to answer central questions about the